"Abbott richt zich met haar producten op het gebied van diagnostiek, medische hulpmiddelen, voeding en farmaceutische producten op de zorgbehoeften van mensen in meer dan 150 landen. Onze diversiteit – qua expertise, technologie en geografie – geeft ons de mogelijkheid om structureel iets te kunnen betekenen voor miljoenen mensen in uiteenlopende regio's en met uiteenlopende culturen."

During the past decade, Abbott Vascular International BVBA conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Abbott Vascular International BVBA" are "Coronary Artery Disease" (2 trials), "Atherosclerosis" (1 trials), "Chronic Total Occlusion of Coronary Artery" (1 trials), "Claudication" (1 trials) and "Coronary Artery Restenosis" (1 trials). Many other conditions were trialed in "Abbott Vascular International BVBA" in a lesser frequency.

Most popular intervention types in "Abbott Vascular International BVBA" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Abbott Vascular ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System" (1 trials), "Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System" (1 trials), "Absorb Bioresorbable Vascular Scaffold" (1 trials) and "ESPRIT BVS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Abbott Vascular International BVBA" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Abbott Vascular International BVBA". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Abbott Vascular International BVBA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Abbott Vascular International BVBA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".